Cargando…
Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA
SUMMARY: We identified factors associated with oral bisphosphonate treatment in 50+-year-old female patients with a first fracture, osteoporosis diagnosis, or BMD ≤−2.5 in the Geisinger Health System electronic health record database. Treatment was positively associated with age, oral corticosteroid...
Autores principales: | Asche, C., Nelson, R., McAdam-Marx, C., Jhaveri, M., Ye, X. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895897/ https://www.ncbi.nlm.nih.gov/pubmed/19798459 http://dx.doi.org/10.1007/s00198-009-1079-7 |
Ejemplares similares
-
Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis
por: Benjamin, Biju, et al.
Publicado: (2016) -
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
por: Yusuf, Akeem A., et al.
Publicado: (2018) -
Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review
por: Fatoye, F, et al.
Publicado: (2019) -
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
por: Cotté, François-Emery, et al.
Publicado: (2011) -
Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)